10/01/2025
Join our Addiction Psychiatry Committee for this great event on October 15th! More about our panelists below! To register, visit nycpsych.org
Dr. Daniel Zimmerman is a clinical instructor at NYU Grossman School of medicine, and is the co-founder of Acheron Psychiatry. Dr. Zimmerman specializes in general psychiatry, psychotherapy, and psychedelic-assisted therapy, including Ketamine-Assisted Psychotherapy (KAP). He completed his psychiatry residency at Harvard MGH-McLean, followed by a Public Psychiatry Fellowship at NYU/Bellevue.
Dr. Mashal Khan is an Assistant Professor of Clinical Psychiatry at Weill Cornell Medicine and the Associate Program Director for the Addiction Psychiatry Fellowship. He completed psychiatry residency at Maimonides Medical Center, and an Addiction Psychiatry Fellowship at Mount Sinai West. His area of interest and clinical focus include technology-assisted interventions for substance use disorders and management of alcohol use disorder in patients with alcohol liver disease. Dr. Khan has recently contributed and served as editor for two books, titled “Technology-Assisted Interventions for Substance Use Disorders” and “From Stigma to Support: A New Vision for Alcohol Use Disorder Treatment and Recovery”.
Dr. Amy Swift is the Deputy Chief Medical Officer of Silver Hill Hospital, where she oversees many services on the campus with special attention to the inpatient services. She completed her psychiatry residency and addiction psychiatry fellowship at Mount Sinai Beth Israel. She is the former Medical Director of Addiction Services at Mount Sinai Beth Israel and former Program Director of their Addiction Psychiatry Fellowship.
Dr. Diana Martinez is a distinguished psychiatric researcher specializing in addiction at Columbia University/New York State Psychiatric Institute, where she is a Professor of Psychiatry. Dr. Martinez completed her psychiatry residency at New York-Presbyterian/Weill Cornell Medical Center. Her current research includes studying the role of neuromodulation in the treatment of substance use disorders.
